|Bid||17.190 x 1400|
|Ask||17.200 x 8200|
|Day's Range||16.910 - 17.330|
|52 Week Range||15.220 - 51.510|
|PE Ratio (TTM)||-2.81|
|Dividend & Yield||1.10 (6.43%)|
|1y Target Est||N/A|
Teva Pharmaceutical Industries’ business has undergone significant turmoil over the past two years, as its stock price clearly indicates. Teva (TEVA) was originally founded in 1901 as a wholesale drug distributor in modern-day Israel. By 2015, Teva was the world’s largest generic pharmaceutical manufacturer.
Teva Pharma (TEVA) and Nuvelution inked a deal to accelerate the development of Austedo (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome.